HealthEquity Price to Sales Ratio 2014-2025 | HQY

Historical PS ratio values for HealthEquity (HQY) over the last 10 years. The current P/S ratio for HealthEquity as of May 28, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
HealthEquity P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-05-28 101.48 7.50
2025-01-31 110.42 $13.54 8.16
2024-10-31 85.25 $13.05 6.53
2024-07-31 78.48 $12.52 6.27
2024-04-30 78.91 $11.95 6.60
2024-01-31 75.58 $11.54 6.55
2023-10-31 71.68 $11.29 6.35
2023-07-31 67.94 $10.98 6.19
2023-04-30 53.45 $10.60 5.04
2023-01-31 60.85 $10.21 5.96
2022-10-31 77.91 $9.89 7.88
2022-07-31 58.17 $9.49 6.13
2022-04-30 62.32 $9.31 6.69
2022-01-31 53.44 $9.12 5.86
2021-10-31 66.18 $9.16 7.23
2021-07-31 73.98 $9.31 7.95
2021-04-30 75.97 $9.48 8.02
2021-01-31 83.55 $9.85 8.48
2020-10-31 51.49 $10.30 5.00
2020-07-31 51.56 $10.23 5.04
2020-04-30 56.27 $9.12 6.17
2020-01-31 66.06 $7.85 8.42
2019-10-31 56.79 $6.11 9.30
2019-07-31 81.98 $4.98 16.46
2019-04-30 67.75 $4.78 14.17
2019-01-31 62.34 $4.53 13.75
2018-10-31 91.80 $4.32 21.27
2018-07-31 75.50 $4.13 18.28
2018-04-30 65.67 $3.93 16.71
2018-01-31 50.62 $3.72 13.61
2017-10-31 50.22 $3.52 14.25
2017-07-31 45.87 $3.33 13.79
2017-04-30 45.52 $3.15 14.47
2017-01-31 46.25 $2.99 15.49
2016-10-31 33.23 $2.81 11.81
2016-07-31 29.52 $2.61 11.32
2016-04-30 25.15 $2.38 10.55
2016-01-31 21.55 $2.16 9.98
2015-10-31 32.71 $2.03 16.12
2015-07-31 33.66 $1.89 17.78
2015-04-30 26.21 $1.88 13.96
Sector Industry Market Cap Revenue
Medical Medical Services $8.748B $1.200B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $135.390B 25.39
Elevance Health (ELV) United States $84.947B 10.96
CVS Health (CVS) United States $77.596B 9.64
Cencora (COR) United States $56.866B 19.78
DiDi Global (DIDIY) China $22.921B 34.79
Natera (NTRA) United States $21.460B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.549B 13.28
EUROFINS SCIENT (ERFSF) Luxembourg $12.465B 0.00
CochLear (CHEOY) Australia $11.562B 0.00
Revvity (RVTY) United States $10.871B 18.71
ICON (ICLR) Ireland $10.610B 9.86
Viatris (VTRS) United States $10.094B 3.47
Doximity (DOCS) United States $9.727B 45.30
Avantor (AVTR) United States $8.961B 13.02
Medpace Holdings (MEDP) United States $8.582B 22.79
Sonic Healthcare (SKHHY) Australia $8.220B 0.00
Charles River Laboratories (CRL) United States $6.810B 13.35
Amplifon S.p.A (AMFPF) Italy $4.966B 27.18
Bausch + Lomb (BLCO) Canada $4.171B 24.58
BrightSpring Health Services (BTSG) United States $4.074B 37.71
Sotera Health (SHC) United States $3.528B 20.05
Surgery Partners (SGRY) United States $2.954B 38.42
Alignment Healthcare (ALHC) United States $2.920B 0.00
Concentras Parent (CON) United States $2.761B 15.96
Organon (OGN) United States $2.376B 2.52
Ardent Health Partners (ARDT) United States $2.127B 9.07
GeneDx Holdings (WGS) United States $1.997B 76.91
Premier (PINC) United States $1.896B 14.39
Progyny (PGNY) United States $1.765B 38.85
PACS (PACS) United States $1.558B 0.00
GoodRx Holdings (GDRX) United States $1.368B 27.36
Teladoc Health (TDOC) United States $1.242B 0.00
Pediatrix Medical (MD) United States $1.190B 9.05
Establishment Labs Holdings (ESTA) $1.067B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.982B 15.33
Agilon Health (AGL) United States $0.923B 0.00
Nutex Health (NUTX) United States $0.911B 13.77
AMN Healthcare Services Inc (AMN) United States $0.822B 7.70
QDM (QDMI) Hong Kong, SAR China $0.743B 0.00
Embecta (EMBC) United States $0.658B 4.43
InnovAge Holding (INNV) United States $0.545B 0.00
Enhabit (EHAB) United States $0.529B 43.54
LifeMD (LFMD) United States $0.524B 0.00
Auna S.A (AUNA) Luxembourg $0.484B 10.90
SBC Medicals (SBC) United States $0.477B 0.00
Sonida Senior Living (SNDA) United States $0.471B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.400B 0.00
Oncology Institute (TOI) United States $0.269B 0.00
Performant Healthcare (PHLT) United States $0.220B 0.00
Beauty Health (SKIN) United States $0.213B 0.00
KindlyMD (NAKA) United States $0.151B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.142B 23.17
OncoCyte (OCX) United States $0.093B 0.00
So-Young (SY) China $0.090B 0.00
Sera Prognostics (SERA) United States $0.063B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
IceCure Medical (ICCM) Israel $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Biodesix (BDSX) United States $0.051B 0.00
Pheton Holdings (PTHL) China $0.038B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
Basel Medical Group (BMGL) Singapore $0.020B 0.00
ModivCare (MODV) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00